Exchange: NASDAQ·Updated 04:11 AM EDT

UTHR News

News
all
press releases
LQDA Stock On Track For Worst Week Ever As Analysts Say The Yutrepia Patent Loss Clouds Its Path
U.S. District Judge Richard G. Andrews of the District of Delaware found on Wednesday that Liquidia induces infringement of claims 1 and 14 of United Therapeutics’ U.S. Patent No. 11,826,327.
Stocktwits
LQDA Stock On Track For Worst Week Ever As Analysts Say The Yutrepia Patent Loss Clouds Its Path
U.S. District Judge Richard G. Andrews of the District of Delaware found on Wednesday that Liquidia induces infringement of claims 1 and 14 of United Therapeutics’ U.S. Patent No. 11,826,327.
Stocktwits
More News
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback
LQDA faces a major setback as a patent ruling threatens Yutrepia's PH-ILD indication and creates uncertainty around its commercial outlook.
Zacks
This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Analysts upgraded BJRI, UTHR, OXY, BP and REGN, raising ratings and/or price targets.read more...
Benzinga
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%
United Therapeutics secures a key patent ruling against Liquidia, potentially limiting Yutrepia's PH-ILD use and reducing competition for its Tyvaso products.
Zacks
Futures Rise As 10Y Yields Pull Back From 24 Year High
Futures Rise As 10Y Yields Pull Back From 24 Year High The disconnect continues. With 10Y yields rising as high as 5.34% - a new 24 year high - before easing back US?equities remain completely oblivious of the tightening in financial conditions and instead are obsessing with the...
Zero Hedge
United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia
Shares of United Therapeutics are rising Thursday following a federal court victory in its patent litigation against competitor Liquidia.read more...
Benzinga
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
United Therapeutics (UTHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
United Therapeutics Wins Patent Case Against Liquidia
(RTTNews) - Wednesday, United Therapeutics Corporation (UTHR) announced that the U.S. District Court for the District of Delaware ruled that Liquidia Technologies (LQDA) infringed claims 1 and 14 of United Therapeutics' U.S. Patent No. 11,826,327, which covers the treatment of pu...
Nasdaq News: Markets
United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the United States District Court for the District of Delaware issued an opinion that finds Liquidia Technologies, Inc. (Liquidia) infringes two claims of United Therapeutics patent covering the use of...
Business Wire
LQDA Stock Eyes Worst Day Ever After Judge Upholds Two UTHR Patent Claims
Liquidia CEO Roger Jeffs said the company disagrees with the court’s decision and will “pursue all available appellate options.”
Stocktwits

Advertisement|Remove ads.